Development of KRAS-degrader drugs against cancer
Category: Pharmaceutical
Exhibitor: DEVELOPMENT CENTER FOR BIOTECHNOLOGY
Booth No: S212a
Characteristic
PROteolysis-Targeting Chimera (PROTAC) is one of the target protein degradation technology. Target proteins can be degraded through ubiquitin labeling and proteasome degradation. PROTAC can be applied to highly resistance targets or undruggable targets.
We apply PROTAC technology on mutated KRAS treatment. It is highly expressed in pancreatic cancer, non-small cell lung cancer and colorectal cancer. By degrading KRAS mutation protein, RAS-PROTAC may show clinical benefit on KRAS highly expressed cancers.
A series of lead compounds exhibited inhibitory effects in cell lines expressed KRAS mutation type G12C, G12D, and G12V as well as significant protein degradation. The in vivo efficacy of the lead compound was observed in NCI-H441 xenograft model with TGI > 60%.
Other Products
-
Pharmacological Model and Biodistribution Platform for Cell Therapy
-
mRNA-LNP Development and Manufacturing
-
Selective FLT3 Inhibitor DCBCO1901 as Precision Medicine
-
High Yield CHO-C Expression System
-
Armored Globo H/IO Blocker CAR-T Cells for Solid Tumor Therapy
Products you may be interested in
-
Bridging Studies
-
IXRS®3 Interactive Response Technology
-
Dermatology Studies
-
TMB-380 (VRC07-523LS)
-
TMB-365/TMB-380 (TMB-365 and TMB-380 combination)
-
TMB-365
-
Research & Development Strategy: Pursue a "Biology First" approach to choose the right targets and tools
-
Therapeutic area - Neuroscience
-
ALA-3000, a 1-month Ketamine released Injectable for treatment-resistant depression
-
Lactate biosensor
-
Prof. Linyi Chen--Small-molecule compounds for neuronal regeneration
-
2-Deoxy-D-glucose
-
Tadalafil
-
Lysozyme Hydrochloride
-
ALA-1000, a 3-month Buprenorphine released injectable for treating opioid use disorder and chronic pain
-
CDMO
-
Cylinder Labeling Machine
-
Antroquinonol ( HOCENA ), new oral drug clinical trial in Covid-19, AML, Lung Cancer, NSCLC, Pancreatic Cancer-Pandemic, Oncology
-
Ropeginterferon alfa-2b
-
DUO Centrifugal Concentrator
-
Development of next generation probiotics using microbiome- and metabolome-based analyses platform
-
Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial
-
【FP-025】 Allergic asthma
-
Acqua delle Terme di Abano 3% Ipertonica 15 Vials from 5 Ml.
-
Octyl b-D-glucopyranoside
Highest Rated Products
-
ELMA 37kHz & 81kHz Ultrasonic Cleaner
-
JASCO HPLC
-
JASCO UV-Visible/NIR Spectrophotometer
-
Small Centrifuge
-
Analytik-Jena Crosslinker
-
EYELA Freeze Dryer
-
Constant Cell Disrupter
-
Benchmark Digital Incubators
-
EYELA Rotary Evaporator
-
JASCO Fourier Transform Infared Microscope
-
Blister line BEC 300
-
A new dawn for the diagnosis of dementia － AI analysis for brain blood flow nuclear images
-
IXRS®3 Interactive Response Technology
-
DR.CYJ HAIR FILLER
-
Data Acquisition and Recording System
-
3D-Printing Model Assisted Nuss Procedure
-
The LAMBDOMA organ resonance
-
Levitronix® PuraLev® Low Shear Single-Use Pump Systems for Bioprocessing
-
PuraLev® i30SU Low Shear Single-Use Pump for Bioprocessing
-
PuraLev® i100SU Low Shear Single-Use Pump for Bioprocessing
-
PuraLev® 200SU Low Shear Single-Use Pump for Bioprocessing
-
PuraLev® 600SU Low Shear Single-Use Pump for Bioprocessing
-
PuraLev® 2000SU Low Shear Single-Use Pump for Bioprocessing
-
Levitronix® LFSC-D Flex Ultrasonic Clamp-On Flow Sensor
-
Levitronix® LCO Console Series
-
Levitronix®PuraLev® Low Shear Multi-Use Pump Systems for Bioprocessing
-
LEVIFLOW® LFS-SU Ultrasonic High-Precision Inline Flow Sensor
-
Ultra low Temperature Freezer
-
EarlyFound MMP-1 ELISA Lit
-
iMist Collagen Mist Spray
